Добірка наукової літератури з теми "Gene and Molecular Therapy"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Gene and Molecular Therapy".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Gene and Molecular Therapy"
M. Gordon, Erlinda, Joshua R. Ravicz, Sant P. Chawla, Christopher W. Szeto, Sant P. Chawla, Michael A. Morse, Frederick L. Hall, and Erlinda M. Gordon. "CCNG1 oncogene: a novel biomarker for cancer therapy /gene therapy." Cancer Research and Cellular Therapeutics 5, no. 4 (August 30, 2021): 01–09. http://dx.doi.org/10.31579/2640-1053/090.
Повний текст джерелаChung, Hesson, Ick Chan Kwon, and Seo Young Jeong. "Gene Therapy and Molecular Imaging." Journal of the Korean Medical Association 47, no. 2 (2004): 139. http://dx.doi.org/10.5124/jkma.2004.47.2.139.
Повний текст джерелаDas, Dipak K., Richard M. Engelman, Nilanjana Maulik, John A. Rousou, Joseph E. Flack, and David W. Deaton. "Molecular targets of gene therapy." Annals of Thoracic Surgery 68, no. 5 (November 1999): 1929–33. http://dx.doi.org/10.1016/s0003-4975(99)01015-2.
Повний текст джерелаEscobar Fernandez, H., A. Zhogov, E. Metzler, R. Kühn, and S. Spuler. "GENE EDITING AND MOLECULAR THERAPY." Neuromuscular Disorders 29 (October 2019): S150. http://dx.doi.org/10.1016/j.nmd.2019.06.399.
Повний текст джерелаRobbins, Jeffrey. "Gene Therapy and Molecular Toxicology." Cardiovascular Toxicology 1, no. 1 (2001): 03–06. http://dx.doi.org/10.1385/ct:1:1:03.
Повний текст джерелаPálffy, R., R. Gardlík, J. Hodosy, M. Behuliak, P. Reško, J. Radvánský, and P. Celec. "Bacteria in gene therapy: bactofection versus alternative gene therapy." Gene Therapy 13, no. 2 (September 15, 2005): 101–5. http://dx.doi.org/10.1038/sj.gt.3302635.
Повний текст джерелаTanaka, N., N. Matsubara, M. Ikeda, H. Takashima, T. Fujiwara, J. Shao, M. Ogawa, T. Fukazawa, and A. Hizuta. "Molecular colorectal tumorigenesis and gene therapy." Nippon Daicho Komonbyo Gakkai Zasshi 51, no. 9 (1998): 686–686. http://dx.doi.org/10.3862/jcoloproctology.51.686.
Повний текст джерелаCehajic Kapetanovic, McClements, Martinez-Fernandez de la Camara, and MacLaren. "Molecular Strategies for RPGR Gene Therapy." Genes 10, no. 9 (September 4, 2019): 674. http://dx.doi.org/10.3390/genes10090674.
Повний текст джерелаGlode, L. Michael. "The molecular bridge to gene therapy." Urology 44, no. 6 (December 1994): 81–88. http://dx.doi.org/10.1016/s0090-4295(94)80249-1.
Повний текст джерелаOrkin, Stuart H. "Molecular genetics and potential gene therapy." Clinical Immunology and Immunopathology 40, no. 1 (July 1986): 151–56. http://dx.doi.org/10.1016/0090-1229(86)90080-2.
Повний текст джерелаДисертації з теми "Gene and Molecular Therapy"
Chen, Ian Ying-Li. "Molecular imaging of cardiac gene therapy /." May be available electronically:, 2008. http://proquest.umi.com/login?COPT=REJTPTU1MTUmSU5UPTAmVkVSPTI=&clientId=12498.
Повний текст джерелаLau, Cara Jean. "Gene therapy for malignant gliomas." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=18478.
Повний текст джерелаLes gliomes sont des tumeurs primaires de cerveau les plus communes retrouvées dans les adultes. La survie médiane des patients diagnostiqués avec la forme la plus maligne, le glioblastome multiforme (GBM), est de 9 à 12 mois et a peu changé au cours des années en dépit des avances en technologie médicale. La thérapie génique peut offrir de nouvelles solutions pour traiter cette maladie résistante. Durant nos travaux, nous avons examiné trois stratégies différentes de thérapie génique Dans notre première étude, nous avons examiné l'efficacité de la thérapie visée à corriger des anomalies communes retrouvées dans les gliomes, comprenant l'amplification/mutation de récepteurs de type tyrosine kinase (RTK) et la perte de PTEN, qui mènent en conséquence à une voie activée de PI3K/Akt. Sans PTEN, les facteurs de transcription FOXO sont inactivés, et la cellule devient résistante à l'arrêt du cycle cellulaire et à l'apoptose. En utilisant un vecteur adénoviral (AdV) exprimant une protéine activée du mutant FOXO1 (AdFOXO1;AAA.), nous avons reconstitué les signaux pour l'arrêt du cycle cellulaire et l'apoptose in vitro ainsi que in vivo. Deuxièmement, nous avons examiné la capacité thérapeutique d'un nouveau vecteur adénovirale qui a la capacité de se répliquer sans provoquer de lyse cellulaire et qui exprime en plus la protéine de fusion uracile phosphoribosyltransférase/cytosine déaminase (CU). La protéine CU peut convertir le promédicament non-toxique, le 5-fluorocytosine (5-FC) à la drogue chimiothérapeutique diffusible, le 5-fluorouracile (5-FU) qui a comme cible des cellules en division cellulaire. In vitro, les vecteurs à capacité de répliquation étaient meilleurs que ceux qui ne pouvaient pas se répliquer. In vivo, le vecteur en présence du 5-FC a prolongé la survie de deux modès animaux (avec et sans sytèmes immunitaires). Dans un dernier temps, nous avons étudié une méthode pour exprimer l'IF
Katabi, Maha M. "Transcriptional targeting of suicide genes in cancer gene therapy." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0021/NQ55345.pdf.
Повний текст джерелаWallace, Lindsay M. "Gene Therapy for Facioscapulohumeral Muscular Dystrophy." The Ohio State University, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=osu1338315498.
Повний текст джерелаRohatgi, Priyanka. "Engineering Protein Molecular Switches To Regulate Gene Expression with Small Molecules." Diss., Georgia Institute of Technology, 2006. http://hdl.handle.net/1853/19852.
Повний текст джерелаYoshida, Jun. "Molecular Neurosurgery Using Gene Therapy to Treat Malignant Glinoma." 名古屋大学医学部, 1996. http://hdl.handle.net/2237/6179.
Повний текст джерелаThraser, Adrian James. "Molecular studies towards gene therapy for chronic granulomatous disease." Thesis, University College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307515.
Повний текст джерелаTiwari, Swati. "Gene Therapy Approaches for Hemophagocytic Lymphohistiocytosis." University of Cincinnati / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1447690858.
Повний текст джерелаMckiver, Bryan D. "SND1-Targeted Gene Therapy for Hepatocellular Carcinoma." VCU Scholars Compass, 2018. https://scholarscompass.vcu.edu/etd/5676.
Повний текст джерелаPerri, Sabrina R. "Exploiting the use of plasminogen kringle domains for cancer gene therapy." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103176.
Повний текст джерелаIn our first study, we assessed the angiostatic properties of the K5 peptide domain in an orthotopic brain cancer model. We demonstrated that the disulfide bridging conformation of K5, necessary to maintain its functionality, is conserved upon secretion by gene-modified mammalian cells. Kringle 5 retrovirally gene-engineered human U87 glioma cells produced functional soluble K5 protein capable of suppressing growth factor-induced endothelial cell migration in vitro and inhibiting glioma-induced angiogenesis in vivo. Interestingly, secreted K5 protein blocked the recruitment of tumor-associated CD45+Mac3 +Grl- macrophages in vivo and inhibited the migration of CD206+ human monocyte-derived macrophages in vitro. Moreover, in a clinically relevant orthotopic glioma model, soluble K5 induced long-term survival in a majority of test animals. Thus, these findings validate the use of a gene therapy approach to deliver Plg K5 protein and suggest that K5 acts as a novel 2-pronged anti-tumor agent, mediating its inhibitory effect via its action on host-derived endothelial cells and tumor-associated macrophages.
To determine if K5 mediated its anti-tumor effect by modulating other immune effector cells, we tested the use of soluble K5 in a murine DA/3 mammary adenocarcinoma model. Soluble K5 produced by retrovirally gene-modified DA/3 cells led to long-term survival (over 1 year) of immunocompetent BALB/c mice however, we failed to observe tumor rejection in immunodeficient NOD-SCID and BALB/c nude mice. Further analysis revealed that K5 enhances the recruitment of tumor-infiltrating CD3+ lymphoid cells, in particular the natural killer T (NKT)-lymphocyte phenotype. Consistent with our previous findings, we demonstrated that K5 led to a significant decrease in tumor-associated microvessel length and density. Interestingly, K5 tumors were characterized by a robust neutrophilic infiltrate. This may be explained by the ability of K5 to act as a strong chemotactic agent for human neutrophils in vitro as well as its ability to promote CD64+ activation within the CD11b+ neutrophil phenotype. These findings confirm that K5 acts as a potent angiostatic agent and possesses a novel pro-inflammatory role via its ability to recruit tumor-associated neutrophils and NKT-lymphocytes, leading to a strong anti-tumor response.
Tumor-associated macrophages (TAM) are key immune effector cells implicated in promoting tumor progression and metastasis. It would thus be desirable to explore strategies to reduce TAM infiltration within the tumor microenvironment. In our first study, we demonstrated that soluble K5 protein blocks macrophage recruitment. In addition, the recent observation that angiostatin reduces macrophage infiltration in an atherosclerosis model prompted our laboratory to further explore the use of angiostatin as an anti-macrophage agent. We demonstrated that angiostatin suppresses the in vitro migration of both murine peritoneal macrophages and human monocyte-derived CD206 + macrophages. Furthermore, we showed that angiostatin led to a decrease in the gelatinolytic activity of macrophage-produced matrix metalloproteinase-9, which may explain, in part, the observed angiostatin-mediated inhibition of migration. Additionally, we detected the presence of the beta-subunit of ATP synthase on the cell-surface of macrophages. ATP synthase was previously found to be a receptor for angiostatin on the cell-surface endothelial cells. We propose that the presence of ATP synthase on the surface of macrophages may promote interaction with angiostatin and prevent migration, similar to what has been reported with endothelial cells. Our findings suggest that angiostatin holds promise as an inhibitory agent against macrophages.
Книги з теми "Gene and Molecular Therapy"
B, Burck Kathy, ed. Gene therapy: Application of molecular biology. New York: Elsevier, 1991.
Знайти повний текст джерелаWiwanitkit, Viroj. Cell, gene, and molecular therapy: New concepts. Hauppauge, NY: Nova Science Publishers, 2009.
Знайти повний текст джерелаGreenwell, Pamela. Molecular therapeutics: 21st-century medicine. Chichester, England: J. Wiley, 2007.
Знайти повний текст джерелаThe new healers: The promise and problems of molecular medicine in the twenty-first century. New York: Oxford University Press, 1997.
Знайти повний текст джерелаBo, Xuenong, and Joost Verhaagen. Gene delivery and therapy for neurological disorders. New York: Humana Press, 2015.
Знайти повний текст джерелаMonaco), Miami Bio/Technology European Symposium (1994. Advances in gene technology: Molecular biology of human genetic disease. Oxford: IRL Press at Oxford University Press, 1994.
Знайти повний текст джерелаFalk Symposium (88th 1995 Basel, Switzerland). Molecular diagnosis and gene therapy: Proceedings of the 88th Falk Symposium (part III of the Basel Liver Week), held in Basel, Switzerland, October 22-23, 1995. Dordrecht: Kluwer Academic Publishers, 1996.
Знайти повний текст джерелаShulin, Li, ed. Electroporation protocols: Experimental and clinical gene medicine. Totowa, N.J: Humana, 2008.
Знайти повний текст джерелаThe lung: Molecular basis of disease. Philadelphia: W.B. Saunders Co., 1998.
Знайти повний текст джерелаBoulikas, Teni. Gene Therapy and Molecular Biology. Gene Therapy Press, 1998.
Знайти повний текст джерелаЧастини книг з теми "Gene and Molecular Therapy"
Cornetta, Kenneth. "Gene Therapy." In Molecular Genetic Pathology, 717–29. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-405-6_29.
Повний текст джерелаWeber, Georg F. "Gene Therapy." In Molecular Therapies of Cancer, 283–96. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13278-5_8.
Повний текст джерелаDouglas, Joanne T., and David T. Curiel. "Gene Therapy." In Molecular Biology of the Lung, 1–20. Basel: Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-8784-7_1.
Повний текст джерелаNakai, Hiroyuki. "Hepatic Gene Therapy." In Molecular Pathology Library, 343–70. Boston, MA: Springer US, 2010. http://dx.doi.org/10.1007/978-1-4419-7107-4_23.
Повний текст джерелаLiu, Ning, and Rhonda Bassel-Duby. "Molecular Basis of Muscle Disease." In Muscle Gene Therapy, 13–39. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03095-7_2.
Повний текст джерелаSchepelmann, Silke, Ion Niculescu-Duvaz, and Caroline J. Springer. "Suicide Gene Therapy." In Principles of Molecular Oncology, 367–82. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-470-4_18.
Повний текст джерелаHoffman, Robert M., Kenji Miki, Waddah Al-Refaie, Mingxu Xu, and Yuying Tan. "Methioninase Gene Therapy." In Methods in Molecular Biology, 173–97. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-8796-2_14.
Повний текст джерелаNiculescu-Duvaz, Ion, and Caroline J. Springer. "Suicide Gene Therapy." In Principles of Molecular Oncology, 675–94. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-664-5_20.
Повний текст джерелаVassalli, Giuseppe, and David A. Dichek. "Cardiovascular Gene Therapy." In Principles of Molecular Medicine, 161–68. Totowa, NJ: Humana Press, 1998. http://dx.doi.org/10.1007/978-1-59259-726-0_18.
Повний текст джерелаHildebrand, Staffan, and Alexander Pfeifer. "Gene Therapy Vectors." In Encyclopedia of Molecular Pharmacology, 689–94. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57401-7_63.
Повний текст джерелаТези доповідей конференцій з теми "Gene and Molecular Therapy"
"Advances in Gene Therapy." In International Conference on Cellular & Molecular Biology and Medical Sciences. Universal Researchers (UAE), 2016. http://dx.doi.org/10.17758/uruae.ae0916417.
Повний текст джерелаPrates, Pedro Emílio Gomes. "AVALIAÇÃO DA TERAPIA GÊNICA DO SUICÍDIO COM USO DE GENES SUICIDAS PARA O COMBATE AO CÂNCER: REVISÃO INTEGRATIVA." In II Congresso Brasileiro de Biologia Molecular On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/2334.
Повний текст джерелаDeng, Xu-Bin, Li Xiao, Fang Jin, Joseph Testa, and Guang-Hui Xiao. "Abstract A64: Adenovirus-mediated NK4 gene therapy for malignant mesothelioma." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a64.
Повний текст джерелаLittle, Annette S., Jessica Hunt, David Hughes, Ruth Feltell, Daniel Gitterman, Rachel Leah, Holly Astley, Ramu Mangena, Kyla Grimshaw, and Christopher Torrance. "Abstract A148: Modeling patient responses to targeted therapy with rAAV mediated gene editing." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-a148.
Повний текст джерелаZhang, Xue-Qing, Mark Chen, Robert Lam, Xiaoyang Xu, Eiji Osawa, and Dean Ho. "A Platform Approach to Gene Delivery via Surface Modified Nanodiamonds." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13340.
Повний текст джерелаPinho, Rafaela Seixas, Afonso Moraes Melo Junior, Rafael Silva Lemos, Amanda da Silva Furtado, and Luís Eduardo Werneck de Carvalho. "Gliomas: tumor markers and prognosis." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.538.
Повний текст джерелаLi, Jianbo, and Hao Lin. "The Role of Ion Electrophoresis in Electroporation-Mediated Molecular Delivery." In ASME 2009 Second International Conference on Micro/Nanoscale Heat and Mass Transfer. ASMEDC, 2009. http://dx.doi.org/10.1115/mnhmt2009-18495.
Повний текст джерелаGurskaya, N. A., and K. V. Kobets. "THE RELATIONSHIP OF POLYMORPHIC VARIANTS OF ESTROGEN RECEPTOR GENES WITH THE DEVELOPMENT OF OSTEOPOROSIS IN THE BELARUSIAN POPULATION." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute, 2021. http://dx.doi.org/10.46646/sakh-2021-1-245-248.
Повний текст джерелаAckerley, David F., Janine N. Copp, Elsie M. Williams, Alexandra M. Mowday, Christopher P. Guise, Gareth A. Prosser, Sophie P. Syddall, Jeff B. Smaill, and Adam V. Patterson. "Abstract B88: Discovery, characterization, and engineering of bacterial nitroreductases for gene-directed enzyme prodrug therapy." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-b88.
Повний текст джерелаSadler, J. Evan. "THE MOLECULAR BIOLOGY OF VON WILLEBRAND FACTOR." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643930.
Повний текст джерелаЗвіти організацій з теми "Gene and Molecular Therapy"
Mohan, Subburaman. Molecular Genetic and Gene Therapy Studies of the Musculoskeletal System. Fort Belvoir, VA: Defense Technical Information Center, September 2009. http://dx.doi.org/10.21236/ada512941.
Повний текст джерелаMohan, Subburaman. Molecular Genetic and Gene Therapy Studies of the Musculoskeletal System. Fort Belvoir, VA: Defense Technical Information Center, February 2007. http://dx.doi.org/10.21236/ada469196.
Повний текст джерелаMohan, Subburaman. Molecular Genetic and Gene Therapy Studies of the Musculoskeletal System. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada469369.
Повний текст джерелаWahl, Geoffrey M. Amplified Genes in Breast Cancer: Molecular Targets for Investigation and Therapy. Fort Belvoir, VA: Defense Technical Information Center, September 1999. http://dx.doi.org/10.21236/ada382811.
Повний текст джерелаGomer, Charles J. Photodynamic Therapy Oxidative Stress as a Molecular Switch Controlling Therapeutic Gene Expression for the Treatment of Locally Recurrent Breast Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada396793.
Повний текст джерелаGaugler, Randy, Itamar Glazer, Daniel Segal, and Sarwar Hashmi. Molecular Approach for Improving the Stability of Insecticidal Nematodes. United States Department of Agriculture, November 2002. http://dx.doi.org/10.32747/2002.7580680.bard.
Повний текст джерелаMeir, Shimon, Michael S. Reid, Cai-Zhong Jiang, Amnon Lers, and Sonia Philosoph-Hadas. Molecular Studies of Postharvest Leaf and Flower Senescence. United States Department of Agriculture, January 2011. http://dx.doi.org/10.32747/2011.7592657.bard.
Повний текст джерелаOhad, Nir, and Robert Fischer. Regulation of plant development by polycomb group proteins. United States Department of Agriculture, January 2008. http://dx.doi.org/10.32747/2008.7695858.bard.
Повний текст джерелаRafaeli, Ada, and Russell Jurenka. Molecular Characterization of PBAN G-protein Coupled Receptors in Moth Pest Species: Design of Antagonists. United States Department of Agriculture, December 2012. http://dx.doi.org/10.32747/2012.7593390.bard.
Повний текст джерелаTucker, Mark L., Shimon Meir, Amnon Lers, Sonia Philosoph-Hadas, and Cai-Zhong Jiang. Elucidation of signaling pathways that regulate ethylene-induced leaf and flower abscission of agriculturally important plants. United States Department of Agriculture, January 2012. http://dx.doi.org/10.32747/2012.7597929.bard.
Повний текст джерела